Search
Sharan Murugan
- May 1
- 2 min
USFDA Guidance: Considerations for the Use of Human-and Animal-Derived Materials & Recognition and Use of a Standard for Uniform Blood & Blood Component Container Labels
Yesterday (30 April 2024), the FDA released a draft guidance for the industry titled "Considerations for the Use of Human-and...
17 views0 comments
Sharan Murugan
- Feb 7
- 2 min
Saudi's SFDA: Good Manufacturing Practice for Blood Establishments
Blood establishments play a crucial role in ensuring a safe and adequate supply of blood for transfusion and other medical purposes. To...
28 views0 comments
Sharan Murugan
- Oct 17, 2023
- 2 min
USFDA Guidance: Policy for Testing of Alcohol & Developing Drugs for DFI Treatment
Earlier today (17 October 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research and Center for...
15 views0 comments
Sharan Murugan
- May 13, 2023
- 1 min
USFDA Guidance: Testing of Glycerin & High Risk Drug Components & CBER Guidances on Blood Products
This week (11 & 12 May 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research and Center for...
46 views0 comments
Sharan Murugan
- Mar 24, 2022
- 1 min
USFDA's recent Guidance on Biologics: Ophthalmic Products & Development of (CAR) T Cell Products
1. Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR This guidance is intended to provide information to applicants...
18 views0 comments